name of glp 1 drugs GLP-1 medication and its types GLP-1 Drug Comparison in Diabetes
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 97.Maekawa R, Ogata H, Murase M, Harada N, Suzuki K, et al
Want ongoing provider involvement throughout treatment
Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data
Second, it directly suppresses appetite through central nervous system signaling
Buckley STSS, Kirk RK, Knudsen LB
More gas accumulates
